reduce insulin dose when starting glp-1 receptor agonist agonists Frontiers | GLP−1 receptor agonists

Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: a model-based approach

This review outlines the mechanistic pathways through which GLP-1 RAs influence BP, summarizes RCT evidence across relevant populations, and discusses implications for clinical practice and future research

And in adults on PAP therapy, Zepbound led to 29 fewer breathing disruptions per hour (compared to six with placebo)

Nausea and vomiting are less frequent in patients receiving EX-LAR than in patients taking EX (114)

Koehler JA, Baggio LL, Cao X, Abdulla T, Campbell JE, Secher T, Jelsing J, Larsen B, and Drucker DJ

doi: 10.1016/S1474-4422(15)00141-6 51 ZhengMWangP